- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 13.41M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 13.39M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 13.38M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 13.15M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 13.13M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $51.98M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $49.52M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $1.15M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $7.12M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $6.82M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $5.72M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $485.29M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $534.13M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $767.41M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $700.57M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.27B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.26B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.45 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.35 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.14 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.04 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.45 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.35 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $0.14 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.04 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $4.86M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $14.51M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $4.38M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $13.42M |
| Revenue | Q3 2025 · Sep 30, 2025 | $37.23M |
| Revenue | Q3 2025 · Sep 30, 2025 | $109.82M |
| Revenue | Q3 2025 · Sep 30, 2024 | $34.26M |
| Revenue | Q3 2025 · Sep 30, 2024 | $103.62M |